Gline Matthew 4
4 · Roivant Sciences Ltd. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Gline Matthew
DirectorCEO
Transactions
- Purchase
Common Shares
2025-09-18$15.07/sh+3,315$49,957→ 17,287,081 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range.